Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2024

Open Access 26-10-2023 | Opioids | Research Article

Understanding general practitioners’ prescribing choices to patients with chronic low back pain: a discrete choice experiment

Authors: Melanie Hamilton, Chung-Wei Christine Lin, Sheena Arora, Mark Harrison, Marguerite Tracy, Brooke Nickel, Christina Abdel Shaheed, Danijela Gnjidic, Stephanie Mathieson

Published in: International Journal of Clinical Pharmacy | Issue 1/2024

Login to get access

Abstract

Background

Although NSAIDs are recommended as a first line analgesic treatment, opioids are very commonly prescribed to patients with low back pain (LBP) despite risks of harms.

Aim

This study aimed to determine factors contributing to general practitioners’ (GPs’) prescribing choices to patients with chronic LBP in a primary care setting.

Method

This discrete choice experiment (DCE) presented 210 GPs with hypothetical scenarios of a patient with chronic LBP. Participants chose their preferred treatment for each choice set, either the opioid, NSAID or neither. The scenarios varied by two patient attributes; non-specific LBP or LBP with referred leg pain (sciatica) and number of comorbidities. The three treatment attributes also varied, being: the type of opioid or NSAID, degree of pain reduction and number of adverse events. The significance of each attribute in influencing clinical decisions was the primary outcome and the degree to which GPs preferred the alternative based on the number of adverse events or the amount of pain reduction was the secondary outcome.

Results

Overall, GPs preferred NSAIDs (45.2%, 95% CI 38.7–51.7%) over opioids (28.8%, 95% CI 23.0–34.7%), however there was no difference between the type of NSAID or opioid preferred. Additionally, the attributes of pain reduction and adverse events did not influence a GP’s choice between NSAIDs or opioids for patients with chronic LBP.

Conclusion

GPs prefer prescribing NSAIDs over opioids for a patient with chronic low back pain regardless of patient factors of comorbidities or the presence of leg pain (i.e. sciatica).
Appendix
Available only for authorised users
Literature
1.
go back to reference Bennett MI, Kaasa S, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain. 2019;160(1):38–44.CrossRefPubMed Bennett MI, Kaasa S, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain. 2019;160(1):38–44.CrossRefPubMed
2.
go back to reference Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.CrossRefPubMed Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.CrossRefPubMed
3.
go back to reference GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;10053:1545–602. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;10053:1545–602.
4.
go back to reference Koes BW, Van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care. Spine. 2001;26(22):2504–13.CrossRefPubMed Koes BW, Van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care. Spine. 2001;26(22):2504–13.CrossRefPubMed
5.
go back to reference Wheeler LP, Karran EL, Harvie DS. Low back Pain. RACGP. 2018;47(9):610–3. Wheeler LP, Karran EL, Harvie DS. Low back Pain. RACGP. 2018;47(9):610–3.
6.
go back to reference Downie A, Williams C, Henschke N, et al. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ. 2013;347. Downie A, Williams C, Henschke N, et al. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ. 2013;347.
7.
go back to reference Bardin LD, King P, Maher CG. Diagnostic triage for low back pain: a practical approach for primary care. Med J Aust. 2017;206:268–73.CrossRefPubMed Bardin LD, King P, Maher CG. Diagnostic triage for low back pain: a practical approach for primary care. Med J Aust. 2017;206:268–73.CrossRefPubMed
8.
go back to reference Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27:2791–803.CrossRefPubMed Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27:2791–803.CrossRefPubMed
9.
go back to reference O’Connell NE, Cook CE, Wand BM, et al. Clinical guidelines for low back pain: a critical review of consensus and inconsistencies across three major guidelines. Best Pract Res Clin Rheumatol. 2016;30(6):968–80.CrossRefPubMed O’Connell NE, Cook CE, Wand BM, et al. Clinical guidelines for low back pain: a critical review of consensus and inconsistencies across three major guidelines. Best Pract Res Clin Rheumatol. 2016;30(6):968–80.CrossRefPubMed
12.
go back to reference Pohjolainen T, Leinonen V, Franten J, et al. Update on current care guideline: low back pain. Duodecim. 2015;131(1):92–4.PubMed Pohjolainen T, Leinonen V, Franten J, et al. Update on current care guideline: low back pain. Duodecim. 2015;131(1):92–4.PubMed
13.
go back to reference National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management 2016. National Institute for Health and Care Excellence, 2016. www.nice.org.uk/guidance/ng59. Accessed 1 May 2022. National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management 2016. National Institute for Health and Care Excellence, 2016. www.​nice.​org.​uk/​guidance/​ng59. Accessed 1 May 2022.
15.
go back to reference Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:4792.CrossRef Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:4792.CrossRef
16.
go back to reference Rutkow L, Vernick JS. Emergency legal authority and the opioid crisis. N Engl J Med. 2017;377(26):2512–4.CrossRefPubMed Rutkow L, Vernick JS. Emergency legal authority and the opioid crisis. N Engl J Med. 2017;377(26):2512–4.CrossRefPubMed
18.
go back to reference Mathieson S, Valenti L, Maher CG, et al. Worsening trends in analgesics recommended for spinal pain in primary care. Eur Spine J. 2018;27:1136–45.CrossRefPubMed Mathieson S, Valenti L, Maher CG, et al. Worsening trends in analgesics recommended for spinal pain in primary care. Eur Spine J. 2018;27:1136–45.CrossRefPubMed
19.
go back to reference Davies E, Sewell B, Jones M, et al. Examining opioid prescribing trends for non-cancer pain using an estimated oral morphine equivalence measure: a retrospective cohort study between 2005 and 2015. BJGP Open. 2021;5:1.CrossRef Davies E, Sewell B, Jones M, et al. Examining opioid prescribing trends for non-cancer pain using an estimated oral morphine equivalence measure: a retrospective cohort study between 2005 and 2015. BJGP Open. 2021;5:1.CrossRef
21.
go back to reference Karanges EA, Blanch B, Buckley NA, et al. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Br J Clin Pharmacol. 2016;82:255–67.PubMedCentralCrossRefPubMed Karanges EA, Blanch B, Buckley NA, et al. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Br J Clin Pharmacol. 2016;82:255–67.PubMedCentralCrossRefPubMed
22.
go back to reference Mathieson S, Wertheimer G, Maher CG, et al. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? systematic review and meta-regression of observational studies. J Intern Med. 2020;287(5):458–74.CrossRefPubMed Mathieson S, Wertheimer G, Maher CG, et al. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? systematic review and meta-regression of observational studies. J Intern Med. 2020;287(5):458–74.CrossRefPubMed
23.
go back to reference Braden JB, Fan MY, Edlund MJ, et al. Trends in use of opioids by noncancer pain type 2000–2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain. 2008;9:1026–35.PubMedCentralCrossRefPubMed Braden JB, Fan MY, Edlund MJ, et al. Trends in use of opioids by noncancer pain type 2000–2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain. 2008;9:1026–35.PubMedCentralCrossRefPubMed
24.
go back to reference Foy R, Leaman B, McCrorie C, et al. Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open. 2016;6: e010276.PubMedCentralCrossRefPubMed Foy R, Leaman B, McCrorie C, et al. Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open. 2016;6: e010276.PubMedCentralCrossRefPubMed
25.
go back to reference Bedson J, Chen Y, Hayward RA, et al. Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study. Pain. 2016;157:1525–31.PubMedCentralCrossRefPubMed Bedson J, Chen Y, Hayward RA, et al. Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study. Pain. 2016;157:1525–31.PubMedCentralCrossRefPubMed
27.
go back to reference Kao MCJ, Minh LC, Huang GY, et al. Trends in ambulatory physician opioid prescription in the United States, 1997–2009. PM&R. 2014;6:575–82.CrossRef Kao MCJ, Minh LC, Huang GY, et al. Trends in ambulatory physician opioid prescription in the United States, 1997–2009. PM&R. 2014;6:575–82.CrossRef
28.
go back to reference Hamilton M, Mathieson S, Gnjidic D, et al. Barriers, facilitators and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia. Pain. 2022;168:518–26.CrossRef Hamilton M, Mathieson S, Gnjidic D, et al. Barriers, facilitators and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia. Pain. 2022;168:518–26.CrossRef
29.
go back to reference McCrorie C, Closs J, House A, et al. Understanding long-term opioid prescribing for non-cancer pain in primary care: a qualitative study. BMC Fam Pract. 2015;16:121.PubMedCentralCrossRefPubMed McCrorie C, Closs J, House A, et al. Understanding long-term opioid prescribing for non-cancer pain in primary care: a qualitative study. BMC Fam Pract. 2015;16:121.PubMedCentralCrossRefPubMed
30.
go back to reference Palagyi A, Keay L, Harper J, et al. Barricades and brickwalls—a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15.PubMedCentralCrossRefPubMed Palagyi A, Keay L, Harper J, et al. Barricades and brickwalls—a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15.PubMedCentralCrossRefPubMed
31.
go back to reference Penney LS, Ritenbaugh C, Debar LL, et al. Provider and patient perspectives on opioids and alternative treatments for managing chronic pain: a qualitative study. BMC Fam Pract. 2016;17:164.CrossRef Penney LS, Ritenbaugh C, Debar LL, et al. Provider and patient perspectives on opioids and alternative treatments for managing chronic pain: a qualitative study. BMC Fam Pract. 2016;17:164.CrossRef
32.
go back to reference Soekhai V, de Bekker-Grob EW, Ellis AR, et al. Discrete choice experiments in health economics: past. Present Future Pharmacoeconomics. 2019;37(2):201–26.CrossRefPubMed Soekhai V, de Bekker-Grob EW, Ellis AR, et al. Discrete choice experiments in health economics: past. Present Future Pharmacoeconomics. 2019;37(2):201–26.CrossRefPubMed
33.
go back to reference Turk D, Boeri M, Abraham L, et al. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthr Cartil. 2020;28:1202–13.CrossRef Turk D, Boeri M, Abraham L, et al. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthr Cartil. 2020;28:1202–13.CrossRef
34.
go back to reference Kløjgaard ME, Manniche C, Bjørnskov Pedersen L, et al. Patient preferences for treatment of low back pain—a discrete choice experiment. Value Health. 2014;17:390–6.CrossRefPubMed Kløjgaard ME, Manniche C, Bjørnskov Pedersen L, et al. Patient preferences for treatment of low back pain—a discrete choice experiment. Value Health. 2014;17:390–6.CrossRefPubMed
35.
go back to reference Hauber AB, Arden NK, Mohamed AF, et al. A discrete-choice experiment of United Kingdom patients’ willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthritis Cartilage. 2013;221:289–97.CrossRef Hauber AB, Arden NK, Mohamed AF, et al. A discrete-choice experiment of United Kingdom patients’ willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthritis Cartilage. 2013;221:289–97.CrossRef
36.
go back to reference Mühlbacher AC, Junker U, Juhnke C, et al. Chronic pain patients’ treatment preferences: a discrete-choice experiment. Eur J Health Econ. 2015;16:613–28.CrossRefPubMed Mühlbacher AC, Junker U, Juhnke C, et al. Chronic pain patients’ treatment preferences: a discrete-choice experiment. Eur J Health Econ. 2015;16:613–28.CrossRefPubMed
37.
go back to reference Davari M, Khorasani E, Molla TB. Factors influencing prescribing decisions of physicians: a review. Ethiop J Sci. 2018;28(6):795. Davari M, Khorasani E, Molla TB. Factors influencing prescribing decisions of physicians: a review. Ethiop J Sci. 2018;28(6):795.
39.
go back to reference Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.CrossRefPubMed Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.CrossRefPubMed
40.
go back to reference Chaparro LE, Furlan AD, Deshpande LM, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane review. Spine. 2014;39(7):556–63.CrossRefPubMed Chaparro LE, Furlan AD, Deshpande LM, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane review. Spine. 2014;39(7):556–63.CrossRefPubMed
41.
go back to reference Machado GC, Maher CM, Ferreira PH, et al. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269–78.CrossRefPubMed Machado GC, Maher CM, Ferreira PH, et al. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269–78.CrossRefPubMed
42.
go back to reference Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–68.CrossRefPubMed Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–68.CrossRefPubMed
43.
go back to reference Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350: h1225.PubMedCentralCrossRefPubMed Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350: h1225.PubMedCentralCrossRefPubMed
44.
go back to reference Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384:1586–96.CrossRefPubMed Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384:1586–96.CrossRefPubMed
46.
go back to reference Els C, Jackson TD, Kunyk D, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10:CD012509.PubMed Els C, Jackson TD, Kunyk D, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10:CD012509.PubMed
47.
go back to reference Enthoven WT, Roelofs PD, Deyo RA, et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087.PubMed Enthoven WT, Roelofs PD, Deyo RA, et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087.PubMed
48.
49.
go back to reference Cairo Notari S, Sader J, Caire Fon N, et al. Understanding GPs’ clinical reasoning processes involved in managing patients suffering from multimorbidity: a systematic review of qualitative and quantitative research. Int J Clin Pract. 2021;75: e14187.CrossRefPubMed Cairo Notari S, Sader J, Caire Fon N, et al. Understanding GPs’ clinical reasoning processes involved in managing patients suffering from multimorbidity: a systematic review of qualitative and quantitative research. Int J Clin Pract. 2021;75: e14187.CrossRefPubMed
50.
go back to reference Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ. 2015;350: h176.CrossRefPubMed Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ. 2015;350: h176.CrossRefPubMed
51.
go back to reference De Bekker-Grob EW, Donkers B, Jonker MF, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–84.PubMedCentralCrossRefPubMed De Bekker-Grob EW, Donkers B, Jonker MF, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–84.PubMedCentralCrossRefPubMed
52.
go back to reference Rose JM, Collins A, Bliemer MC, et al. Ngene 1.0 stated choice experiment design software;2009. University of Sydney. Rose JM, Collins A, Bliemer MC, et al. Ngene 1.0 stated choice experiment design software;2009. University of Sydney.
54.
go back to reference Traets F, Sanchez DG, Vandebroek M. Generating optimal designs for discrete choice experiments in R: the idefix package. J Stat Softw. 2020;96(3):1–41.CrossRef Traets F, Sanchez DG, Vandebroek M. Generating optimal designs for discrete choice experiments in R: the idefix package. J Stat Softw. 2020;96(3):1–41.CrossRef
55.
go back to reference Campbell D, Erdem S. Including opt-out options in discrete choice experiments: issues to consider. Patient. 2019;1:1–14.CrossRef Campbell D, Erdem S. Including opt-out options in discrete choice experiments: issues to consider. Patient. 2019;1:1–14.CrossRef
56.
go back to reference Pearce AM, Mulhern BJ, Watson V, et al. How are debriefing questions used in health discrete choice experiments? An online survey. Value Health. 2020;23(3):289–93.CrossRefPubMed Pearce AM, Mulhern BJ, Watson V, et al. How are debriefing questions used in health discrete choice experiments? An online survey. Value Health. 2020;23(3):289–93.CrossRefPubMed
57.
go back to reference StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021. StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
58.
go back to reference Gray BM, Vandergrift JL, Weng W, et al. Clinical knowledge and trends in physicians’ prescribing of opioids for new onset back pain, 2009–2017. JAMA Netw Open. 2021;4(7): e2115328.PubMedCentralCrossRefPubMed Gray BM, Vandergrift JL, Weng W, et al. Clinical knowledge and trends in physicians’ prescribing of opioids for new onset back pain, 2009–2017. JAMA Netw Open. 2021;4(7): e2115328.PubMedCentralCrossRefPubMed
59.
go back to reference Price SM, O’Donoghue AC, Rizzo L, et al. Opioid education and prescribing practices. JABFM. 2021;34(4):802–7.CrossRefPubMed Price SM, O’Donoghue AC, Rizzo L, et al. Opioid education and prescribing practices. JABFM. 2021;34(4):802–7.CrossRefPubMed
60.
go back to reference Tamblyn R, Girard N, Boulet J, et al. Association of clinical competence, specialty and physician country of origin with opioid prescribing for chronic pain: a cohort study. BMJ Qual Saf. 2022;31:340–52.CrossRefPubMed Tamblyn R, Girard N, Boulet J, et al. Association of clinical competence, specialty and physician country of origin with opioid prescribing for chronic pain: a cohort study. BMJ Qual Saf. 2022;31:340–52.CrossRefPubMed
61.
go back to reference Belavy D, Tagliaferri SD, Buntine P, et al. Clinician education unlikely effective for guideline adherent medication prescription in low back pain: systematic review and meta-analysis of RCTs. Lancet. 2022;43:1–15. Belavy D, Tagliaferri SD, Buntine P, et al. Clinician education unlikely effective for guideline adherent medication prescription in low back pain: systematic review and meta-analysis of RCTs. Lancet. 2022;43:1–15.
62.
go back to reference Britt H, Miller GC, Henderson J, et al. A decade of Australian general practice activity 2004–05 to 2013–14. General practice series No. 37. Sydney University Press. 2014. Britt H, Miller GC, Henderson J, et al. A decade of Australian general practice activity 2004–05 to 2013–14. General practice series No. 37. Sydney University Press. 2014.
64.
go back to reference Goldstick JE, Guy GP, Losby JL, et al. Changes in initial opioid prescribing practices after the 2016 release of the CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Netw Open. 2021;4:7.CrossRef Goldstick JE, Guy GP, Losby JL, et al. Changes in initial opioid prescribing practices after the 2016 release of the CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Netw Open. 2021;4:7.CrossRef
65.
go back to reference Peterson K, Anderson J, Ferguson L, et al. Evidence Brief: The Comparative Effectiveness of Selected Complementary and Integrative Health (CIH) Interventions for Preventing or Reducing Opioid Use in Adults with Chronic Neck, Low Back, and Large Joint Pain. 2016 Apr. In: VA Evidence Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011. Peterson K, Anderson J, Ferguson L, et al. Evidence Brief: The Comparative Effectiveness of Selected Complementary and Integrative Health (CIH) Interventions for Preventing or Reducing Opioid Use in Adults with Chronic Neck, Low Back, and Large Joint Pain. 2016 Apr. In: VA Evidence Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011.
66.
go back to reference Avery N, McNeilage AG, Stanaway F, et al. Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis. BMJ. 2022;377:e066375.PubMedCentralCrossRefPubMed Avery N, McNeilage AG, Stanaway F, et al. Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis. BMJ. 2022;377:e066375.PubMedCentralCrossRefPubMed
67.
go back to reference Koes BW, Van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19:2075–94.PubMedCentralCrossRefPubMed Koes BW, Van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19:2075–94.PubMedCentralCrossRefPubMed
68.
go back to reference Schreijenberg M, Koes BW, Lin CW. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care—is there a need to change? Expert Rev Clin Pharmacol. 2019;12(2):145–57.CrossRefPubMed Schreijenberg M, Koes BW, Lin CW. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care—is there a need to change? Expert Rev Clin Pharmacol. 2019;12(2):145–57.CrossRefPubMed
69.
go back to reference Dowell D, Haegerich TM, Chou R. Centres for disease control and prevention guideline for prescribing opioids for chronic pain. MMWR Recomm Rep. 2016;65:1.CrossRefPubMed Dowell D, Haegerich TM, Chou R. Centres for disease control and prevention guideline for prescribing opioids for chronic pain. MMWR Recomm Rep. 2016;65:1.CrossRefPubMed
70.
go back to reference Friedman BW, Dym AA, Davitt M, et al. Naproxen with cyclobenzaprine, oxycodone/acetaminophen, or placebo for treating acute low back pain: a randomized clinical trial. JAMA. 2015;314:1572–80.CrossRefPubMed Friedman BW, Dym AA, Davitt M, et al. Naproxen with cyclobenzaprine, oxycodone/acetaminophen, or placebo for treating acute low back pain: a randomized clinical trial. JAMA. 2015;314:1572–80.CrossRefPubMed
72.
go back to reference Biezen R, Roberts C, Buising K, et al. How do general practitioners access guidelines and utilise electronic medical records to make clinical decisions on antibiotic use? Results from an Australian qualitative study. BMJ Open. 2019;9: e028329.PubMedCentralCrossRefPubMed Biezen R, Roberts C, Buising K, et al. How do general practitioners access guidelines and utilise electronic medical records to make clinical decisions on antibiotic use? Results from an Australian qualitative study. BMJ Open. 2019;9: e028329.PubMedCentralCrossRefPubMed
73.
go back to reference Mühlbacher AC, Junker U, Juhnke C, et al. Chronic pain patients’ treatment preferences: a discrete-choice experiment. Eur J Health Econ. 2015;16:613–28.CrossRefPubMed Mühlbacher AC, Junker U, Juhnke C, et al. Chronic pain patients’ treatment preferences: a discrete-choice experiment. Eur J Health Econ. 2015;16:613–28.CrossRefPubMed
74.
go back to reference Aboagye E, Hagberg J, Axen I, et al. Individual preferences for physical exercise as secondary prevention for non-specific low back pain: a discrete choice experiment. PLoS ONE. 2017;12: e0187709.PubMedCentralCrossRefPubMed Aboagye E, Hagberg J, Axen I, et al. Individual preferences for physical exercise as secondary prevention for non-specific low back pain: a discrete choice experiment. PLoS ONE. 2017;12: e0187709.PubMedCentralCrossRefPubMed
75.
go back to reference Harrison M, Milbers K, Hudson M, et al. Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open. 2017;7(5):e014719.PubMedCentralCrossRefPubMed Harrison M, Milbers K, Hudson M, et al. Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open. 2017;7(5):e014719.PubMedCentralCrossRefPubMed
76.
go back to reference Punwasi R, Kleijn L, Rijkels-Otters JBM, et al. General practitioners’ attitudes towards opioids for non-cancer pain: a qualitative systematic review. BMJ Open. 2022;12:e054945.PubMedCentralCrossRefPubMed Punwasi R, Kleijn L, Rijkels-Otters JBM, et al. General practitioners’ attitudes towards opioids for non-cancer pain: a qualitative systematic review. BMJ Open. 2022;12:e054945.PubMedCentralCrossRefPubMed
77.
go back to reference Wewege MA, Bagg MK, Jones MD, et al. Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis. BMJ. 2023;380:e072962.PubMedCentralCrossRefPubMed Wewege MA, Bagg MK, Jones MD, et al. Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis. BMJ. 2023;380:e072962.PubMedCentralCrossRefPubMed
Metadata
Title
Understanding general practitioners’ prescribing choices to patients with chronic low back pain: a discrete choice experiment
Authors
Melanie Hamilton
Chung-Wei Christine Lin
Sheena Arora
Mark Harrison
Marguerite Tracy
Brooke Nickel
Christina Abdel Shaheed
Danijela Gnjidic
Stephanie Mathieson
Publication date
26-10-2023
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2024
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-023-01649-y

Other articles of this Issue 1/2024

International Journal of Clinical Pharmacy 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.